High or Low Dose Syntocinon (Oxytocin) for delay in labour
ISRCTN | ISRCTN23847193 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN23847193 |
EudraCT/CTIS number | 2009-012752-24 |
Secondary identifying numbers | 8896 |
- Submission date
- 29/10/2010
- Registration date
- 29/10/2010
- Last edited
- 28/05/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Ms Deborah Bird
Scientific
Scientific
Department of Public Health and Epidemiology
Edgbaston
Birmingham
B15 2TT
United Kingdom
Phone | +44 121 414 6754 |
---|---|
d.bird@bham.ac.uk |
Study information
Study design | Multicentre randomised interventional treatment trial with an observational qualitative element |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | High or Low Dose Syntocinon (Oxytocin) for delay in labour |
Study acronym | HOLDS |
Study objectives | Use of high dose oxytocin will achieve more effective uterine contractions resulting not only in shorter labours but in a higher chance of vaginal birth in women who are diagnosed as having delay in the first stage of labour. |
Ethics approval(s) | 23/06/2010 (ref: 10/H0406/30) |
Health condition(s) or problem(s) studied | Topic: Reproductive Health and Childb; Subtopic: Reproductive Health and Childb (all Subtopics); Disease: Reproductive Health & Childbirth |
Intervention | Syntocinon, 10 IU versus 20 IU Study entry: single randomisation only |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Applicable |
Drug / device / biological / vaccine name(s) | Syntocinon (Oxytocin) |
Primary outcome measure | Birth and early postnatal period |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/11/2010 |
Completion date | 30/09/2011 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Female |
Target number of participants | Planned sample size: 100; UK sample size: 100 |
Total final enrolment | 94 |
Key inclusion criteria | 1. Consenting nulliparous women with a singleton pregnancy at term (37 - 42 weeks) gestation 2. Confirmed delay in labour as defined by NICE Intrapartum Care Guideline and with ruptured membranes 3. Labour is established when there are regular painful contractions and progressive cervical dilation from 4 cm. Delay is suspected when cervical dilatation of less than 2 cm in 4 hours occurs once labour is established. Delay is confirmed when progress of less than 1 cm in 2 hours is found on repeat vaginal examination. |
Key exclusion criteria | 1. Under 16 years old 2. Induction 3. Body mass index (BMI) greater than 40 4. Multiple pregnancy 5. Existing maternal or fetal disease or concern 6. Gestational diabetes 7. Previous uterine surgery 8. Vaginal bleeding in this pregnancy of clinical significance 9. Contra-indication to oxytocin therapy |
Date of first enrolment | 01/11/2010 |
Date of final enrolment | 30/09/2011 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of Public Health and Epidemiology
Birmingham
B15 2TT
United Kingdom
B15 2TT
United Kingdom
Sponsor information
University of Birmingham (UK)
University/education
University/education
Department of Public Health and Epidemiology
Edgbaston
Birmingham
B15 2TT
England
United Kingdom
Website | http://www.staff.bham.ac.uk/ |
---|---|
https://ror.org/03angcq70 |
Funders
Funder type
Government
National Institute for Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB) Programme
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Basic results | 28/05/2020 | No | No | ||
HRA research summary | 28/06/2023 | No | No |
Editorial Notes
28/05/2020: The following changes were made to the trial record:
1.Added clinicaltrialsregister.eu link to basic results (scientific).
2. The total final enrollment was added.
11/05/2017: No publications found in PubMed, verifying study status with principal investigator